Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „inhibit“
Suchtreffer
Begriffe & Kennungen
Abiraterone Accord · 4.5 · Potential to affect exposures to other medicinal products Abiraterone acetate is an inhibitor of the hepatic m
Eintrag öffnenAbiraterone Accord · 4.5 · Potential to affect exposures to other medicinal products Abiraterone acetate is an inhibitor of the hepatic m
Eintrag öffnenAbiraterone Krka · 4.5 · In vitro, the major metabolites abiraterone sulphate and N-oxide abiraterone sulphate were shown to inhibit th
Eintrag öffnenAbiraterone Krka · 4.5 · Potential to affect exposures to other medicinal products Abiraterone is an inhibitor of the hepatic drug-meta
Eintrag öffnenAbiraterone Mylan · 4.5 · In vitro, the major metabolites abiraterone sulphate and N-oxide abiraterone sulphate were shown to inhibit th
Eintrag öffnenAbiraterone Mylan · 4.5 · Potential to affect exposures to other medicinal products Abiraterone is an inhibitor of the hepatic drug-meta
Eintrag öffnenAbnormal circulating plasminogen activator inhibitor 1 activity
Eintrag öffnenAcetaldehyd-Dehydrogenase-Hemmer
Eintrag öffnenAcetylcholin-Freisetzungshemmer
Eintrag öffnenActelsar HCT · 4.5 · Medicinal products that may increase potassium levels or induce hyperkalaemia (e.g. ACE inhibitors, potassium-
Eintrag öffnenActelsar HCT · 4.5 · Medicinal products that may increase potassium levels or induce hyperkalaemia (e.g. ACE inhibitors, potassium-
Eintrag öffnenActelsar HCT · 4.5 · NSAIDs (i.e. acetylsalicylic acid at anti-inflammatory dose regimens, COX-2 inhibitors and non-selective NSAID
Eintrag öffnenActelsar HCT · 4.5 · NSAIDs (i.e. acetylsalicylic acid at anti-inflammatory dose regimens, COX-2 inhibitors and non-selective NSAID
Eintrag öffnenActos · 4.5 · Co-administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) is reported to result
Eintrag öffnenAdasuve · 4.5 · 18 irregular manner. Concomitant use of CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin, enoxacin, proprano
Eintrag öffnenAdasuve · 4.5 · 6 irregular manner. Concomitant use of CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin, enoxacin, propranol
Eintrag öffnenAdasuve · 4.5 · In vitro studies indicated that loxapine was not a substrate for P-glycoprotein (P-gp), but does inhibit P-gp.
Eintrag öffnenAdasuve · 4.5 · In vitro studies indicated that loxapine was not a substrate for P-glycoprotein (P-gp), but does inhibit P-gp.
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin with ketoconazole, a strong CYP3A4 and P-gp inhibitor, increased the
Eintrag öffnenAdcetris · 4.5 · Interaction with medicinal products metabolised through CYP3A4 route (CYP3A4 inhibitors/inducers)
Eintrag öffnen